Northern Ireland’s First Licensed Stem Cell Biobank Set to Revolutionize Life Sciences Infrastructure

In a groundbreaking move that promises to transform Northern Ireland’s life sciences landscape, Derry-based startup LifeCellsNI is preparing to launch the region’s first licensed stem cell biobank, backed by a £590,000 pre-seed investment round that signals growing confidence in the province’s biotech potential.

The investment, led by The AMP Angel Syndicate with crucial support from Co-Fund III managed by Clarendon Fund Managers, will fund the establishment of a state-of-the-art cryogenic storage and laboratory processing hub in Ebrington Square, Derry. The facility, expected to launch later this year, will operate under the rigorous UK Human Tissue Authority (HTA) governance frameworks, bringing world-class regulatory compliance to Northern Ireland’s burgeoning life sciences sector.

Currently, Northern Ireland faces a significant infrastructure gap in the life sciences sector. The absence of locally regulated long-term storage facilities for stem cells and therapeutic tissues has created a bottleneck for patients, clinics, and research organizations, who must ship biological material to mainland UK. This not only increases regulatory complexity and operational costs but also limits the region’s ability to participate fully in advanced therapy programs and regenerative medicine research.

LifeCellsNI is positioning itself to fill this critical gap by offering a comprehensive suite of services that go far beyond simple storage. The company will provide HTA-licensed cryogenic storage, controlled laboratory processing, and secure chain-of-custody management with compliant cold-chain logistics. Additionally, they plan to offer contingency biobanking services for healthcare providers, universities, and private companies, effectively democratizing access to sophisticated biobanking infrastructure.

“Our facility is designed not only to serve families preserving cord blood but also to support health trusts, universities, and private life sciences companies requiring compliant storage and processing capability without investing in their own infrastructure,” explained Catherine King, founder and CEO of LifeCellsNI. “Infrastructure determines participation. If a region lacks regulated biobanking capability, it limits its ability to engage fully in advanced therapy programmes and regenerative medicine research. We are building that missing piece.”

King brings substantial expertise to the venture, with a background in healthcare innovation and ecosystem development. She has worked closely with clinicians, researchers, and regional innovation bodies to develop life sciences capabilities across Northern Ireland. Her approach reflects a deep understanding of both the technical requirements of stem cell storage and the broader ecosystem needed to support a thriving biotech sector.

The implications of LifeCellsNI’s initiative extend well beyond immediate storage needs. By establishing compliant infrastructure locally, the company is effectively removing a significant barrier to entry for advanced therapy medicinal product development and cellular research across the island of Ireland. This could catalyze a new wave of innovation in regenerative medicine, potentially positioning Northern Ireland as a hub for cutting-edge life sciences research and development.

Looking ahead, LifeCellsNI has ambitious plans to expand its service offerings to include ethically governed donor cell collection and supply, further supporting advanced therapy medicinal product development and cellular research. This forward-thinking approach suggests the company aims to be more than just a storage facility – they envision becoming a central node in a growing life sciences ecosystem.

The company’s journey to this point has been marked by strategic support from various regional innovation partners. Founded in 2022, LifeCellsNI was incubated within The AMP Growth Incubator ecosystem and has received backing from Invest Northern Ireland, the Founder Labs pre-accelerator programme, the Health Innovation Research Alliance of Northern Ireland, the NHS Confed’s NICON Conference, and Derry City & Strabane District Council. This broad base of support underscores the perceived importance of the company’s mission to regional economic development and healthcare advancement.

The timing of LifeCellsNI’s launch is particularly significant given the global push toward personalized medicine and regenerative therapies. As healthcare systems worldwide increasingly recognize the potential of stem cell therapies for treating a range of conditions, from blood disorders to degenerative diseases, the availability of compliant storage and processing infrastructure becomes crucial. LifeCellsNI’s facility could position Northern Ireland to attract research partnerships, clinical trials, and potentially even biotech companies looking for a strategic location with supportive infrastructure.

From an economic perspective, the establishment of this facility represents more than just a business venture – it’s an investment in Northern Ireland’s future as a life sciences hub. By creating the necessary infrastructure, LifeCellsNI is helping to build the foundation upon which a robust biotech ecosystem can develop, potentially creating high-skilled jobs and attracting further investment to the region.

The HTA licensing that LifeCellsNI will operate under is particularly noteworthy. This certification ensures that the facility meets the highest standards for the storage and processing of human tissue, providing assurance to both healthcare providers and research institutions. It also means that samples stored at the facility can be used in clinical applications, not just research, potentially accelerating the translation of scientific discoveries into patient treatments.

As LifeCellsNI prepares for its launch, the broader implications for Northern Ireland’s healthcare system are significant. The availability of local, compliant stem cell storage could improve access to regenerative therapies for patients across the region, while also supporting the work of clinicians and researchers pushing the boundaries of what’s possible in medicine.

The success of LifeCellsNI could also serve as a model for other regions facing similar infrastructure gaps, demonstrating how targeted investment in specialized facilities can unlock broader economic and healthcare benefits. As the life sciences sector continues to evolve rapidly, the importance of such foundational infrastructure cannot be overstated.

stem cell biobank
cryogenic storage
life sciences infrastructure
regenerative medicine
biobanking services
HTA licensing
Northern Ireland biotech
advanced therapy medicinal products
cellular research
cord blood storage
life sciences ecosystem
biotech investment
healthcare innovation
compliant storage
cold-chain logistics
stem cell processing
therapeutic tissues
medical research
biotech startup
regional development
personalized medicine
clinical trials
high-skilled jobs
biotech hub
human tissue authority
laboratory processing
chain-of-custody management
ethical governance
donor cell collection
medical infrastructure
healthcare ecosystem
biotechnology
stem cell therapy
tissue storage
research facilities
medical innovation
biotech funding
angel investment
Clarendon Fund Managers
AMP Angel Syndicate
Invest Northern Ireland
Founder Labs
Health Innovation Research Alliance
NHS Confed
NICON Conference
Derry City Council
Strabane District Council
Ebrington Square
life sciences capabilities
advanced therapies
regenerative healthcare
biomedical research
tissue banking
medical storage
cellular therapy
stem cell research
biotech ecosystem
healthcare infrastructure
regional innovation
medical technology
biotech development
stem cell applications
therapeutic development
clinical research
medical compliance
biotech facilities
life sciences investment
healthcare advancement
medical breakthroughs
stem cell potential
tissue processing
biobanking infrastructure
medical partnerships
research collaboration
biotech growth
stem cell preservation
medical facilities
healthcare research
biotech opportunities
stem cell future
tissue regulation
medical standards
biotech leadership
stem cell impact
healthcare transformation
medical progress

,